HB 1198
Pub
Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.
- Tennessee
- House / Assembly
- Introduced Feb 6, 2025
- Session 114
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Tennessee’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
25 actions-
Pub. Ch. 206
-
Effective date(s) 04/11/2025
-
Signed by Governor.
-
Signed by Senate Speaker
-
Transmitted to Governor for his action.
-
Enrolled; ready for sig. of H. Speaker.
-
Signed by H. Speaker
-
H. adopted am. (Amendment 1 - HA0140)
-
Sponsor(s) Added.
-
Passed H., as am., Ayes 92, Nays 1, PNV 0
-
Engrossed; ready for transmission to Sen.
-
Received from House, Passed on First Consideration
-
Senate substituted House Bill for companion Senate Bill.
-
Amendment withdrawn. (Amendment 1 - SA0236)
-
Passed Senate, Ayes 30, Nays 0
-
H. Placed on Regular Calendar for 3/31/2025
-
Placed on cal. Calendar & Rules Committee for 3/27/2025
-
Rec. for pass. if am., ref. to Calendar & Rules Committee
-
Rec for pass if am by s/c ref. to Insurance Committee
-
Placed on cal. Insurance Committee for 3/19/2025
-
Placed on s/c cal Insurance Subcommittee for 3/12/2025
-
P2C, ref. to Insurance Committee
-
Assigned to s/c Insurance Subcommittee
-
Intro., P1C.
-
Filed for introduction